Skip to main content
logo
Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
13.44
+0.46 (3.54%)
At close: Jul 27, 2026, 4:00 PM EDT
13.43
-0.01 (-0.07%)
Pre-market: Jul 28, 2026, 4:57 AM EDT

Greenwich LifeSciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
10.516.184.096.9913.4727.2
Cash & Short-Term Investments
10.516.184.096.9913.4727.2
Cash Growth
282.02%50.98%-41.45%-48.10%-50.49%-5.08%
Total Current Assets
10.516.184.096.9913.4727.2
Other Intangible Assets
--00.010.010.01
Total Assets
10.516.184.096.9913.4827.22

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4.514.872.80.260.220.22
Other Current Liabilities
0.730.950.380.040.040.16
Total Current Liabilities
5.245.823.190.290.260.39
Total Liabilities
5.245.823.190.290.260.39

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010.01
Additional Paid-in Capital
98.0587.4868.6757.0554.6760.47
Retained Earnings
-92.79-87.14-67.78-50.36-41.47-33.65
Shareholders' Equity
5.270.350.916.713.2126.83
Total Liabilities & Equity
10.516.184.096.9913.4827.22

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
10.516.184.096.9913.4727.2
Net Cash Growth
282.02%50.98%-41.45%-48.10%-50.49%-5.08%
Net Cash Per Share
0.780.460.310.541.042.10
Book Value
5.270.350.916.713.2126.83
Book Value Per Share
0.390.030.070.521.022.07
Tangible Book Value
5.270.350.916.713.2126.82
Tangible Book Value Per Share
0.390.030.070.521.022.07
SEC Filings: 10-K · 10-Q